Fundz

Junevity raised $10M in seed funding led by Goldcrest Capital and Godfrey Capital to enhance its RESET platform for developing cell reset therapeutics for longevity.

PRIVATEFeb 13, 2025

Amount Raised

$10 Million

Round Type

Seed

San FranciscoBiotechnologyHealth CareGeneticsTherapeutics

Investors

Goldcrest CapitalGodfrey Capital

Description

Junevity, a biotechnology company focused on extending lifespan and healthspan, announced $10 million in seed funding. The funding will be used to enhance the RESET platform and develop therapeutic candidates targeting Type 2 diabetes, obesity, and frailty.

Quick answer

Junevity raised $10 Million in a Seed round, dated February 13, 2025. Investors: Goldcrest Capital and Godfrey Capital. Junevity is based in San Francisco, California, United States.

How much did Junevity raise?
Junevity raised $10 Million in a Seed round on February 13, 2025.
Who invested in Junevity?
Goldcrest Capital and Godfrey Capital are named as investors in this round.
What does Junevity do?
Junevity is a longevity biotechnology company developing Cell Reset therapeutics.
Where is Junevity based and how big is it?
Junevity is based in San Francisco, California, United States. Fundz records about 13 employees.
Who are the decision-makers at Junevity?
Fundz holds 1 contact at Junevity, including the Co-founder, Chief Operating and Business Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Genetics and Therapeutics around the same time

Companies in the same sectors as Junevity that raised within 45 days of this round, from Fundz verified event records.

  • Epicrispr Biotechnologies raised $68M (Series B) on March 27, 2025.
  • Entos Pharmaceuticals raised $4M (Seed) on February 5, 2025.
  • NewcelX raised $2M (Seed) on March 28, 2025.
  • Tribune Therapeutics raised $40M (Seed) on March 26, 2025.
  • Surrozen raised $76M on March 26, 2025.
  • Hillstar Bio raised $67M (Series A) on March 25, 2025.

Who to call at Junevity, and when

A new round usually means Junevity is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Junevity raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Junevity, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Junevity. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Junevity

Location

San Francisco, California, United States

About

Junevity is a longevity biotechnology company developing Cell Reset therapeutics. The RESET Platform is the first to use large-scale human data and AI to develop novel siRNA therapeutics targeting transcription factors. Founded out of UCSF in 2023, Junevity’s mission is to extend human lifespan and healthspan.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Junevity raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsRob C., Co-founder, Chief Operating and Busines…See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Junevity's next move

See what Strategic adds

Junevity raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.